DA9601
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for DA9601, covering 2014-09-30 to 2025-08-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of DA9601 for Acute and Chronic Gastritis and to Determine the Optimal Clinical Dosage and Administration [Phase 2]